These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 17448412

  • 1. The effect of spironolactone use on heart failure mortality: a population-based study.
    Ouzounian M, Hassan A, Cox JL, Johnstone DE, Howlett J, Improving Cardiovascular Outcomes in Nova Scotia Study Investigators.
    J Card Fail; 2007 Apr; 13(3):165-9. PubMed ID: 17448412
    [Abstract] [Full Text] [Related]

  • 2. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people.
    Jhund PS, Macintyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A, Chalmers JW, Capewell S, McMurray JJ.
    Circulation; 2009 Feb 03; 119(4):515-23. PubMed ID: 19153268
    [Abstract] [Full Text] [Related]

  • 3. Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001.
    Masoudi FA, Gross CP, Wang Y, Rathore SS, Havranek EP, Foody JM, Krumholz HM.
    Circulation; 2005 Jul 05; 112(1):39-47. PubMed ID: 15983243
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.
    Shah KB, Rao K, Sawyer R, Gottlieb SS.
    J Am Coll Cardiol; 2005 Sep 06; 46(5):845-9. PubMed ID: 16139135
    [Abstract] [Full Text] [Related]

  • 6. Appropriateness of spironolactone prescribing in heart failure patients: a population-based study.
    Ko DT, Juurlink DN, Mamdani MM, You JJ, Wang JT, Donovan LR, Tu JV.
    J Card Fail; 2006 Apr 06; 12(3):205-10. PubMed ID: 16624686
    [Abstract] [Full Text] [Related]

  • 7. Identifying opportunities to address the congestive heart failure burden: the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) study.
    Howlett JG, Johnstone DE, Sketris I, O'Reilly M, Horne GS, Cox JL, Improving Cardiovascular Outcomes in Nova Scotia investigators.
    Can J Cardiol; 2003 Mar 31; 19(4):439-44. PubMed ID: 12704493
    [Abstract] [Full Text] [Related]

  • 8. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM, Abraham WT, Albert NM, Clare R, Gattis Stough W, Gheorghiade M, Greenberg BH, Yancy CW, Young JB, Fonarow GC.
    Am Heart J; 2008 Oct 31; 156(4):662-73. PubMed ID: 18926148
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX, Ye X, Lee KY, Dupclay L, Plauschinat C.
    Clin Ther; 2008 Oct 31; 30 Pt 2():2217-27. PubMed ID: 19281916
    [Abstract] [Full Text] [Related]

  • 12. Translating guidelines into clinical practice: benefits of an acute heart failure unit .
    Fonseca C, Ceia F, Sarmento PM, Marques F, Covas R, Aleixo A.
    Rev Port Cardiol; 2007 Nov 31; 26(11):1111-28. PubMed ID: 18297836
    [Abstract] [Full Text] [Related]

  • 13. Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Greenberg BH, Abraham WT, Albert NM, Chiswell K, Clare R, Stough WG, Gheorghiade M, O'Connor CM, Sun JL, Yancy CW, Young JB, Fonarow GC.
    Am Heart J; 2007 Aug 31; 154(2):277.e1-8. PubMed ID: 17643576
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association of spironolactone use with all-cause mortality in heart failure: a propensity scored cohort study.
    Lund LH, Svennblad B, Melhus H, Hallberg P, Dahlström U, Edner M.
    Circ Heart Fail; 2013 Mar 31; 6(2):174-83. PubMed ID: 23386667
    [Abstract] [Full Text] [Related]

  • 17. Statin therapy and clinical outcomes in heart failure: a propensity-matched analysis.
    Ouzounian M, Tu JV, Austin PC, Chong A, Liu PP, Lee DS.
    J Card Fail; 2009 Apr 31; 15(3):241-8. PubMed ID: 19327626
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of blood pressure at hospital discharge with mortality in patients diagnosed with heart failure.
    Lee DS, Ghosh N, Floras JS, Newton GE, Austin PC, Wang X, Liu PP, Stukel TA, Tu JV.
    Circ Heart Fail; 2009 Nov 31; 2(6):616-23. PubMed ID: 19919987
    [Abstract] [Full Text] [Related]

  • 20. Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study).
    Vardeny O, Wu DH, Desai A, Rossignol P, Zannad F, Pitt B, Solomon SD, RALES Investigators.
    J Am Coll Cardiol; 2012 Nov 13; 60(20):2082-9. PubMed ID: 23083787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.